Teva- Pharmaceutical Industries Ltd
Teva- Pharmaceutical Industries Ltd (TEVA) Option Chain
As of September 25, 2026, Teva- Pharmaceutical Industries Ltd is trading at $39.19, a -2.57% change from the previous close. The nearest expiration is Oct 2, 2026. Implied volatility is 31.9%. IV Rank is 11%.
Read more
Tracking the TEVA option chain helps you see every strike and expiry on Teva- Pharmaceutical Industries Ltd in one view, so you can quickly identify the contracts that fit your thesis and your risk. Teva- Pharmaceutical Industries Ltd's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TEVA options activity at a glance. Use our scanner to monitor the TEVA option chain in real time and filter for the TEVA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TEVA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TEVA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TEVA stock options are being actively traded and where they are not.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas.
Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Teva- Pharmaceutical Industries Ltd's full chain across every expiry, highlights the most liquid strikes, and lets you screen TEVA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TEVA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile37.70% Neutral
- Market cap (M$)45,668
- 52 weeks high-3.92%
- 52 weeks low114.50%
- Analyst recommendationStrong Buy
1.40 - Target price$44.20
12.78% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-03
- P/E65.34
- Future P/E12.76
- EPS (ttm)0.60
- EPS growth next 5 years5.56%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 23.94 | 159 | 12 | 0.31 | 1.19 | 1.16 | 1.83 | 38.00 | -3.04 | 0.14 | 0.37 | 0.00 | 0.26 | 5 | 22 | 76.06 |
| 34.23 | 239 | 4 | 0.36 | 0.69 | 0.77 | 1.33 | 38.50 | -1.76 | 0.25 | 0.60 | 0.00 | 0.43 | 0 | 52 | 65.77 |
| 45.70 | 271 | 53 | 0.62 | 0.19 | 0.70 | 0.92 | 39.00 | -0.48 | 0.54 | 0.92 | 0.00 | 0.73 | 24 | 303 | 54.30 |
| 57.39 | 56 | 7 | 0.51 | 0.00 | 0.41 | 0.60 | 39.50 | +0.79 | 0.77 | 1.04 | 0.31 | 0.59 | 25 | 99 | 42.61 |
| 68.33 | 890 | 116 | 0.36 | 0.00 | 0.25 | 0.47 | 40.00 | +2.07 | 0.89 | 1.56 | 0.81 | 0.41 | 3 | 204 | 31.67 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full TEVA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→